(Q43443984)

23 November 2017

Economic factors in of patients' nonadherence to antidepressant treatment (English)

1 reference

23 November 2017

1 reference

Haekyung Jeon-Slaughter

series ordinal

1

object named as

Haekyung Jeon-Slaughter

1 reference

23 November 2017

14 March 2012

1 reference

Social Psychiatry and Psychiatric Epidemiology

23 November 2017

1 reference

23 November 2017

47

1 reference

23 November 2017

12

1 reference

23 November 2017

1985-1998

1 reference

National trends in the outpatient treatment of depression

23 November 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

National trends in psychotropic medication polypharmacy in office-based psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

National patterns in antidepressant medication treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Optimizing outcomes in depression: focus on antidepressant compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Tolerability and adherence issues in antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Persistence and compliance to antidepressant treatment in patients with depression: a chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Medication compliance and persistence: terminology and definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Treatment non-adherence in affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Compliance with prescribed drugs: challenges for the elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

A checklist for medication compliance and persistence studies using retrospective databases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Predictors of response to treatment for chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

The effects of antidepressant medication adherence as well as psychosocial and clinical factors on depression outcome among older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Attitudes towards drugs--a survey in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Effect of patient socioeconomic status on perceptions of first- and second-year medical students

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Reducing drug costs at a Veterans Affairs hospital by increasing market-share of generic fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Predictors of self-reported antidepressant adherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Prevalence and treatment of mental disorders, 1990 to 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Effects of ethnicity on psychotropic medications adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Race and trust in the health care system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Under the shadow of Tuskegee: African Americans and health care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Perceived racism, medication adherence, and hospital admission in African-Caribbean patients with psychosis in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Using patient characteristics and attitudinal data to identify depression treatment preference groups: a latent-class model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Discontinuation of use and switching of antidepressants: influence of patient-physician communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Effect of mental health specialty care on antidepressant length of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Primary care patients with depression are less accepting of treatment than those seen by mental health specialists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Continuity of antidepressant treatment for adults with depression in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Use of antidepressants by general practitioners and psychiatrists in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Predictors of antidepressant adherence: results of a Japanese Internet-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Compliance during treatment with antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Non-adherence with psychotropic medications in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Relationships between multiple self-reported nonadherence measures and pharmacy records

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

The effect of patient race and socio-economic status on physicians' perceptions of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Perceived Stigma as a Predictor of Treatment Discontinuation in Young and Older Outpatients With Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Why don't patients take their medicine? Reasons and solutions in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-012-0497-6

Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication.

21 January 2018

1 reference

12 December 2020

Continuity is the main challenge in treating major depressive disorder in psychiatric care.

1 reference

12 December 2020

Compliance with antidepressant therapy and antidepressant discontinuation symptoms

1 reference

12 December 2020

STAR*D: what have we learned?

1 reference

12 December 2020

Maintenance Phase Efficacy of Sertraline for Chronic Depression A Randomized Controlled Trial

1 reference

12 December 2020

Dropout from outpatient mental health care in the United States

1 reference

12 December 2020

Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events

1 reference

12 December 2020

Antidepressant medication management and Health Plan Employer Data Information Set (HEDIS) criteria: reasons for nonadherence

1 reference

12 December 2020

Noncompliance with antidepressants: who's to blame?

1 reference

12 December 2020

Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis

1 reference

12 December 2020

Differential prescription of maintenance antipsychotics to African American and white patients with new-onset bipolar disorder

1 reference

12 December 2020

Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study

1 reference

12 December 2020

The role of the primary care physician in patients' adherence to antidepressant therapy.

1 reference

12 December 2020

Once-daily bupropion associated with improved patient adherence compared with twice-daily bupropion in treatment of depression

1 reference

12 December 2020

The effect of an educational leaflet on depressive patients' attitudes toward treatment

1 reference

12 December 2020

Factors impacting the selection of antidepressant treatment in patients with major depressive disorder at risk for nonadherence.

1 reference

12 December 2020

Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment

1 reference

12 December 2020

Racial/ethnic differences in physician distrust in the United States

1 reference

12 December 2020

Nontricyclic antidepressants: predictors of nonadherence

1 reference

12 December 2020

Attitudes and beliefs of patients of first episode depression towards antidepressants and their adherence to treatment

1 reference

12 December 2020

Antidepressant medication adherence: a study of primary care patients

1 reference

12 December 2020

10.1007/S00127-012-0497-6

Identifiers

DOI

1 reference

23 November 2017

1 reference

PubMed ID

22415606